Bertrand Pain, Camille Baquerre, Muriel Coulpier. Vet Res 2021
Times Cited: 1
Times Cited: 1
Times Cited
Times Co-cited
Similarity
A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.
Julian R F Walters, Ali M Tasleem, Omer S Omer, W Gordon Brydon, Tracy Dew, Carel W le Roux. Clin Gastroenterol Hepatol 2009
Julian R F Walters, Ali M Tasleem, Omer S Omer, W Gordon Brydon, Tracy Dew, Carel W le Roux. Clin Gastroenterol Hepatol 2009
100
Evaluating the Role of Solubility in Oral Absorption of Poorly Water-Soluble Drugs Using Physiologically-Based Pharmacokinetic Modeling.
Christina Fink, Dajun Sun, Knut Wagner, Melanie Schneider, Holger Bauer, Hugues Dolgos, Karsten Mäder, Sheila-Annie Peters. Clin Pharmacol Ther 2020
Christina Fink, Dajun Sun, Knut Wagner, Melanie Schneider, Holger Bauer, Hugues Dolgos, Karsten Mäder, Sheila-Annie Peters. Clin Pharmacol Ther 2020
100
Dermatologic side effects associated with gefitinib therapy: clinical experience and management.
Roy S Herbst, Patricia M LoRusso, Michele Purdom, Deborah Ward. Clin Lung Cancer 2003
Roy S Herbst, Patricia M LoRusso, Michele Purdom, Deborah Ward. Clin Lung Cancer 2003
100
EGFR inhibitor-driven endoplasmic reticulum stress-mediated injury on intestinal epithelial cells.
Shaocheng Hong, Yanhong Gu, Zhenzhen Gao, Lele Guo, Wenjie Guo, Xudong Wu, Yan Shen, Yang Sun, Xuefeng Wu, Qiang Xu. Life Sci 2014
Shaocheng Hong, Yanhong Gu, Zhenzhen Gao, Lele Guo, Wenjie Guo, Xudong Wu, Yan Shen, Yang Sun, Xuefeng Wu, Qiang Xu. Life Sci 2014
100
HCT116 cells deficient in p21(Waf1) are hypersensitive to tyrosine kinase inhibitors and adriamycin through a mechanism unrelated to p21 and dependent on p53.
Nuria Ferrandiz, Jorge Martin-Perez, Rosa Blanco, Derya Donertas, Axel Weber, Martin Eilers, Paolo Dotto, M Dolores Delgado, Javier Leon. DNA Repair (Amst) 2009
Nuria Ferrandiz, Jorge Martin-Perez, Rosa Blanco, Derya Donertas, Axel Weber, Martin Eilers, Paolo Dotto, M Dolores Delgado, Javier Leon. DNA Repair (Amst) 2009
100
Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.
Benoît Busser, Lucie Sancey, Véronique Josserand, Carole Niang, Marie C Favrot, Jean-Luc Coll, Amandine Hurbin. Mol Ther 2010
Benoît Busser, Lucie Sancey, Véronique Josserand, Carole Niang, Marie C Favrot, Jean-Luc Coll, Amandine Hurbin. Mol Ther 2010
100
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy.
Charles Pottier, Margaux Fresnais, Marie Gilon, Guy Jérusalem, Rémi Longuespée, Nor Eddine Sounni. Cancers (Basel) 2020
Charles Pottier, Margaux Fresnais, Marie Gilon, Guy Jérusalem, Rémi Longuespée, Nor Eddine Sounni. Cancers (Basel) 2020
100
Trimmomatic: a flexible trimmer for Illumina sequence data.
Anthony M Bolger, Marc Lohse, Bjoern Usadel. Bioinformatics 2014
Anthony M Bolger, Marc Lohse, Bjoern Usadel. Bioinformatics 2014
100
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening.
Minsuh Kim, Hyemin Mun, Chang Oak Sung, Eun Jeong Cho, Hye-Joon Jeon, Sung-Min Chun, Da Jung Jung, Tae Hoon Shin, Gi Seok Jeong, Dong Kwan Kim,[...]. Nat Commun 2019
Minsuh Kim, Hyemin Mun, Chang Oak Sung, Eun Jeong Cho, Hye-Joon Jeon, Sung-Min Chun, Da Jung Jung, Tae Hoon Shin, Gi Seok Jeong, Dong Kwan Kim,[...]. Nat Commun 2019
100
The intestinotrophic peptide, glp-2, counteracts intestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, gefitinib.
Kristine Juul Hare, Bolette Hartmann, Hannelouise Kissow, Jens Juul Holst, Steen Seier Poulsen. Clin Cancer Res 2007
Kristine Juul Hare, Bolette Hartmann, Hannelouise Kissow, Jens Juul Holst, Steen Seier Poulsen. Clin Cancer Res 2007
100
Ultra high content image analysis and phenotype profiling of 3D cultured micro-tissues.
Zi Di, Maarten J D Klop, Vasiliki-Maria Rogkoti, Sylvia E Le Dévédec, Bob van de Water, Fons J Verbeek, Leo S Price, John H N Meerman. PLoS One 2014
Zi Di, Maarten J D Klop, Vasiliki-Maria Rogkoti, Sylvia E Le Dévédec, Bob van de Water, Fons J Verbeek, Leo S Price, John H N Meerman. PLoS One 2014
100
Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors.
P Yaish, A Gazit, C Gilon, A Levitzki. Science 1988
P Yaish, A Gazit, C Gilon, A Levitzki. Science 1988
100
Human Enteroids/Colonoids and Intestinal Organoids Functionally Recapitulate Normal Intestinal Physiology and Pathophysiology.
Nicholas C Zachos, Olga Kovbasnjuk, Jennifer Foulke-Abel, Julie In, Sarah E Blutt, Hugo R de Jonge, Mary K Estes, Mark Donowitz. J Biol Chem 2016
Nicholas C Zachos, Olga Kovbasnjuk, Jennifer Foulke-Abel, Julie In, Sarah E Blutt, Hugo R de Jonge, Mary K Estes, Mark Donowitz. J Biol Chem 2016
100
Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods.
M Aickin, H Gensler. Am J Public Health 1996
M Aickin, H Gensler. Am J Public Health 1996
100
Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling.
Nipha Chaicharoenaudomrung, Phongsakorn Kunhorm, Parinya Noisa. World J Stem Cells 2019
Nipha Chaicharoenaudomrung, Phongsakorn Kunhorm, Parinya Noisa. World J Stem Cells 2019
100
Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells.
Hiroshi Ariyama, Baoli Qin, Eishi Baba, Risa Tanaka, Kenji Mitsugi, Mine Harada, Shuji Nakano. J Cell Biochem 2006
Hiroshi Ariyama, Baoli Qin, Eishi Baba, Risa Tanaka, Kenji Mitsugi, Mine Harada, Shuji Nakano. J Cell Biochem 2006
100
The ConsensusPathDB interaction database: 2013 update.
Atanas Kamburov, Ulrich Stelzl, Hans Lehrach, Ralf Herwig. Nucleic Acids Res 2013
Atanas Kamburov, Ulrich Stelzl, Hans Lehrach, Ralf Herwig. Nucleic Acids Res 2013
100
Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol.
Helen C Swaisland, Malcolm Ranson, Robert P Smith, Joanna Leadbetter, Alison Laight, David McKillop, Martin J Wild. Clin Pharmacokinet 2005
Helen C Swaisland, Malcolm Ranson, Robert P Smith, Joanna Leadbetter, Alison Laight, David McKillop, Martin J Wild. Clin Pharmacokinet 2005
100
Physiologically Based Pharmacokinetic Modeling to Evaluate the Systemic Exposure of Gefitinib in CYP2D6 Ultrarapid Metabolizers and Extensive Metabolizers.
Yingxue Chen, Diansong Zhou, Weifeng Tang, Wangda Zhou, Nidal Al-Huniti, Eric Masson. J Clin Pharmacol 2018
Yingxue Chen, Diansong Zhou, Weifeng Tang, Wangda Zhou, Nidal Al-Huniti, Eric Masson. J Clin Pharmacol 2018
100
Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.
Trudy Rodgers, Malcolm Rowland. J Pharm Sci 2006
Trudy Rodgers, Malcolm Rowland. J Pharm Sci 2006
100
The Reactome Pathway Knowledgebase.
Antonio Fabregat, Steven Jupe, Lisa Matthews, Konstantinos Sidiropoulos, Marc Gillespie, Phani Garapati, Robin Haw, Bijay Jassal, Florian Korninger, Bruce May,[...]. Nucleic Acids Res 2018
Antonio Fabregat, Steven Jupe, Lisa Matthews, Konstantinos Sidiropoulos, Marc Gillespie, Phani Garapati, Robin Haw, Bijay Jassal, Florian Korninger, Bruce May,[...]. Nucleic Acids Res 2018
100
WikiPathways: connecting communities.
Marvin Martens, Ammar Ammar, Anders Riutta, Andra Waagmeester, Denise N Slenter, Kristina Hanspers, Ryan A Miller, Daniela Digles, Elisson N Lopes, Friederike Ehrhart,[...]. Nucleic Acids Res 2021
Marvin Martens, Ammar Ammar, Anders Riutta, Andra Waagmeester, Denise N Slenter, Kristina Hanspers, Ryan A Miller, Daniela Digles, Elisson N Lopes, Friederike Ehrhart,[...]. Nucleic Acids Res 2021
100
Gefitinib and erlotinib in metastatic non-small cell lung cancer: a meta-analysis of toxicity and efficacy of randomized clinical trials.
Mauricio Burotto, Elisabet E Manasanch, Julia Wilkerson, Tito Fojo. Oncologist 2015
Mauricio Burotto, Elisabet E Manasanch, Julia Wilkerson, Tito Fojo. Oncologist 2015
100
Human organoids: model systems for human biology and medicine.
Jihoon Kim, Bon-Kyoung Koo, Juergen A Knoblich. Nat Rev Mol Cell Biol 2020
Jihoon Kim, Bon-Kyoung Koo, Juergen A Knoblich. Nat Rev Mol Cell Biol 2020
100
A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine.
Simon Plummer, Stephanie Wallace, Graeme Ball, Roslyn Lloyd, Paula Schiapparelli, Alfredo Quiñones-Hinojosa, Thomas Hartung, David Pamies. Sci Rep 2019
Simon Plummer, Stephanie Wallace, Graeme Ball, Roslyn Lloyd, Paula Schiapparelli, Alfredo Quiñones-Hinojosa, Thomas Hartung, David Pamies. Sci Rep 2019
100
Side effects of therapy: case 1. Nephrotic syndrome associated with gefitinib therapy.
Ryuichiro Kumasaka, Norio Nakamura, Kenichi Shirato, Hiroshi Osawa, Shingo Takanashi, Yukihiro Hasegawa, Hideaki Yamabe, Masayuki Nakamura, Michiko Tamura, Ken Okumura. J Clin Oncol 2004
Ryuichiro Kumasaka, Norio Nakamura, Kenichi Shirato, Hiroshi Osawa, Shingo Takanashi, Yukihiro Hasegawa, Hideaki Yamabe, Masayuki Nakamura, Michiko Tamura, Ken Okumura. J Clin Oncol 2004
100
Establishment of Gastrointestinal Epithelial Organoids.
Maxime M Mahe, Eitaro Aihara, Michael A Schumacher, Yana Zavros, Marshall H Montrose, Michael A Helmrath, Toshiro Sato, Noah F Shroyer. Curr Protoc Mouse Biol 2013
Maxime M Mahe, Eitaro Aihara, Michael A Schumacher, Yana Zavros, Marshall H Montrose, Michael A Helmrath, Toshiro Sato, Noah F Shroyer. Curr Protoc Mouse Biol 2013
100
High cholesterol in lipid rafts reduces the sensitivity to EGFR-TKI therapy in non-small cell lung cancer.
Qiufang Chen, Zhenzhen Pan, Min Zhao, Qin Wang, Chen Qiao, Liyun Miao, Xuansheng Ding. J Cell Physiol 2018
Qiufang Chen, Zhenzhen Pan, Min Zhao, Qin Wang, Chen Qiao, Liyun Miao, Xuansheng Ding. J Cell Physiol 2018
100
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.
A Goncalves, M Fabbro, C Lhommé, L Gladieff, J-M Extra, A Floquet, L Chaigneau, A Tisseron Carrasco, P Viens. Gynecol Oncol 2008
A Goncalves, M Fabbro, C Lhommé, L Gladieff, J-M Extra, A Floquet, L Chaigneau, A Tisseron Carrasco, P Viens. Gynecol Oncol 2008
100
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche.
Toshiro Sato, Robert G Vries, Hugo J Snippert, Marc van de Wetering, Nick Barker, Daniel E Stange, Johan H van Es, Arie Abo, Pekka Kujala, Peter J Peters,[...]. Nature 2009
Toshiro Sato, Robert G Vries, Hugo J Snippert, Marc van de Wetering, Nick Barker, Daniel E Stange, Johan H van Es, Arie Abo, Pekka Kujala, Peter J Peters,[...]. Nature 2009
100
Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro.
Ping Fang, Xiang Zheng, Jiayang He, Honglei Ge, Pengfei Tang, Jianping Cai, Guoxin Hu. Drug Des Devel Ther 2017
Ping Fang, Xiang Zheng, Jiayang He, Honglei Ge, Pengfei Tang, Jianping Cai, Guoxin Hu. Drug Des Devel Ther 2017
100
Organoids as an in vitro model of human development and disease.
Aliya Fatehullah, Si Hui Tan, Nick Barker. Nat Cell Biol 2016
Aliya Fatehullah, Si Hui Tan, Nick Barker. Nat Cell Biol 2016
100
Cytochrome P450-mediated metabolism in the human gut wall.
Kirstin Thelen, Jennifer B Dressman. J Pharm Pharmacol 2009
Kirstin Thelen, Jennifer B Dressman. J Pharm Pharmacol 2009
100
Quantitative Systems Toxicology Modeling To Address Key Safety Questions in Drug Development: A Focus of the TransQST Consortium.
Sofia Ferreira, Ciarán Fisher, Laura I Furlong, Loic Laplanche, Brian Kevin Park, Carmen Pin, Julio Saez-Rodriguez, Panuwat Trairatphisan. Chem Res Toxicol 2020
Sofia Ferreira, Ciarán Fisher, Laura I Furlong, Loic Laplanche, Brian Kevin Park, Carmen Pin, Julio Saez-Rodriguez, Panuwat Trairatphisan. Chem Res Toxicol 2020
100
AURKA upregulation plays a role in fibroblast-reduced gefitinib sensitivity in the NSCLC cell line HCC827.
Jia Chen, Huiqi Lu, Wang Zhou, Huabin Yin, Lishuang Zhu, Chang Liu, Pengfei Zhang, Huimin Hu, Yili Yang, Huanxing Han. Oncol Rep 2015
Jia Chen, Huiqi Lu, Wang Zhou, Huabin Yin, Lishuang Zhu, Chang Liu, Pengfei Zhang, Huimin Hu, Yili Yang, Huanxing Han. Oncol Rep 2015
100
Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors in patients with epidermal growth factor receptor gene mutation-positive lung cancer.
Masayuki Takeda, Kazuhiko Nakagawa. Mol Clin Oncol 2017
Masayuki Takeda, Kazuhiko Nakagawa. Mol Clin Oncol 2017
100
Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis.
Mark C Howell, Ryan Green, Roukiah Khalil, Elspeth Foran, Waise Quarni, Rajesh Nair, Stanley Stevens, Aleksandr Grinchuk, Andrew Hanna, Shyam Mohapatra,[...]. FASEB Bioadv 2019
Mark C Howell, Ryan Green, Roukiah Khalil, Elspeth Foran, Waise Quarni, Rajesh Nair, Stanley Stevens, Aleksandr Grinchuk, Andrew Hanna, Shyam Mohapatra,[...]. FASEB Bioadv 2019
100
Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients.
Jing Li, Julie Brahmer, Wells Messersmith, Manuel Hidalgo, Sharyn D Baker. Invest New Drugs 2006
Jing Li, Julie Brahmer, Wells Messersmith, Manuel Hidalgo, Sharyn D Baker. Invest New Drugs 2006
100
Regional Differences in Human Intestinal Drug Metabolism.
Raditya Iswandana, Marina I Irianti, Dorenda Oosterhuis, Hendrik S Hofker, Marjolijn T Merema, Marina H de Jager, Henricus A M Mutsaers, Peter Olinga. Drug Metab Dispos 2018
Raditya Iswandana, Marina I Irianti, Dorenda Oosterhuis, Hendrik S Hofker, Marjolijn T Merema, Marina H de Jager, Henricus A M Mutsaers, Peter Olinga. Drug Metab Dispos 2018
100
Establishment of 2D Cell Cultures Derived From 3D MCF-7 Spheroids Displaying a Doxorubicin Resistant Profile.
Ana S Nunes, Elisabete C Costa, Andreia S Barros, Duarte de Melo-Diogo, Ilídio J Correia. Biotechnol J 2019
Ana S Nunes, Elisabete C Costa, Andreia S Barros, Duarte de Melo-Diogo, Ilídio J Correia. Biotechnol J 2019
100
Cholesterol Biosynthesis: A Mechanistic Overview.
Nuno M F S A Cerqueira, Eduardo F Oliveira, Diana S Gesto, Diogo Santos-Martins, Cátia Moreira, Hari N Moorthy, Maria J Ramos, P A Fernandes. Biochemistry 2016
Nuno M F S A Cerqueira, Eduardo F Oliveira, Diana S Gesto, Diogo Santos-Martins, Cátia Moreira, Hari N Moorthy, Maria J Ramos, P A Fernandes. Biochemistry 2016
100
Side effects related to cancer treatment: CASE 1. Hepatitis following treatment with gefitinib.
Cheryl Ho, Jennifer Davis, Frank Anderson, Gwyn Bebb, Nevin Murray. J Clin Oncol 2005
Cheryl Ho, Jennifer Davis, Frank Anderson, Gwyn Bebb, Nevin Murray. J Clin Oncol 2005
100
New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids.
Daniela Rodrigues, Terezinha de Souza, Luke Coyle, Matteo Di Piazza, Bram Herpers, Sofia Ferreira, Mian Zhang, Johanna Vappiani, Daniel C Sévin, Attila Gabor,[...]. Arch Toxicol 2021
Daniela Rodrigues, Terezinha de Souza, Luke Coyle, Matteo Di Piazza, Bram Herpers, Sofia Ferreira, Mian Zhang, Johanna Vappiani, Daniel C Sévin, Attila Gabor,[...]. Arch Toxicol 2021
100
VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays.
C Fisher, S Siméon, M Jamei, I Gardner, Y F Bois. Toxicol In Vitro 2019
C Fisher, S Siméon, M Jamei, I Gardner, Y F Bois. Toxicol In Vitro 2019
100
Effects of polymorphisms in CYP2D6 and ABC transporters and side effects induced by gefitinib on the pharmacokinetics of the gefitinib metabolite, O-desmethyl gefitinib.
Hiroyuki Kobayashi, Kazuhiro Sato, Takenori Niioka, Masahide Takeda, Yuji Okuda, Mariko Asano, Hiroshi Ito, Masatomo Miura. Med Oncol 2016
Hiroyuki Kobayashi, Kazuhiro Sato, Takenori Niioka, Masahide Takeda, Yuji Okuda, Mariko Asano, Hiroshi Ito, Masatomo Miura. Med Oncol 2016
100
Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines.
Heyan Li, Songwen Zhou, Xuefei Li, Daoyuan Wang, Yongsheng Wang, Caicun Zhou, Gerald Schmid-Bindert. Cancer Biother Radiopharm 2013
Heyan Li, Songwen Zhou, Xuefei Li, Daoyuan Wang, Yongsheng Wang, Caicun Zhou, Gerald Schmid-Bindert. Cancer Biother Radiopharm 2013
100
The Simcyp population-based ADME simulator.
Masoud Jamei, Steve Marciniak, Kairui Feng, Adrian Barnett, Geoffrey Tucker, Amin Rostami-Hodjegan. Expert Opin Drug Metab Toxicol 2009
Masoud Jamei, Steve Marciniak, Kairui Feng, Adrian Barnett, Geoffrey Tucker, Amin Rostami-Hodjegan. Expert Opin Drug Metab Toxicol 2009
100
Pharmacokinetics of Gefitinib: Roles of Drug Metabolizing Enzymes and Transporters.
Can Zhao, Shu-Yan Han, Ping-Ping Li. Curr Drug Deliv 2017
Can Zhao, Shu-Yan Han, Ping-Ping Li. Curr Drug Deliv 2017
100
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.